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Risk factors for mortality and effect of correct fluid 
prescription in children with diarrhoea and dehydration 
without severe acute malnutrition admitted to Kenyan 
hospitals: an observational, association study 
Samuel Akech, Philip Ayieko, David Gathara, Ambrose Agweyu, Grace Irimu, Kasia Stepniewska, Mike English, on behalf of the Clinical 
Information Network authors*
Summary
Background Diarrhoea causes many deaths in children younger than 5 years and identification of risk factors for 
death is considered a global priority. The effectiveness of currently recommended fluid management for dehydration 
in routine settings has also not been examined.
Methods For this observational, association study, we analysed prospective clinical data on admission, immediate 
treatment, and discharge of children age 1–59 months with diarrhoea and dehydration, which were routinely collected 
from 13 Kenyan hospitals. We analysed participants with full datasets using multivariable mixed-effects logistic 
regression to assess risk factors for in-hospital death and effect of correct rehydration on early mortality (within 2 days).
Findings Between Oct 1, 2013, and Dec 1, 2016, 8562 children with diarrhoea and dehydration were admitted to hospital 
and eligible for inclusion in this analysis. Overall mortality was 9% (759 of 8562 participants) and case fatality was directly 
correlated with severity. Most children (7184 [84%] of 8562) with diarrhoea and dehydration had at least one additional 
diagnosis (comorbidity). Age of 12 months or younger (adjusted odds ratio [AOR] 1·71, 95% CI 1·42–2·06), female sex 
(1·41, 1·19–1·66), diarrhoea duration of more than 14 days (2·10, 1·42–3·12), abnormal respiratory signs (3·62, 
2·95–4·44), abnormal circulatory signs (2·29, 1·89–2·77), pallor (2·15, 1·76–2·62), use of intravenous fluid (proxy for 
severity; 1·68, 1·41–2·00), and abnormal neurological signs (3·07, 2·54–3·70) were independently associated with in-
hospital mortality across hospitals. Signs of dehydration alone were not associated with in-hospital deaths (AOR 1·08, 
0·87–1·35). Correct fluid prescription significantly reduced the risk of early mortality (within 2 days) in all subgroups: 
abnormal respiratory signs (AOR 1·23, 0·68–2·24), abnormal circulatory signs (0·95, 0·53–1·73), pallor (1·70, 
0·95–3·02), dehydration signs only (1·50, 0·79–2·88), and abnormal neurological signs (0·86, 0·51–1·48).
Interpretation Children at risk of in-hospital death are those with complex presentations rather than uncomplicated 
dehydration, and the prescription of recommended rehydration guidelines reduces risk of death. Strategies to 
optimise the delivery of recommended guidance should be accompanied by studies on the management of 
dehydration in children with comorbidities, the vulnerability of young girls, and the delivery of immediate care.
Funding The Wellcome Trust.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Introduction
Mortality from diarrhoea has decreased since the 1990s, but 
it still causes up to 0·6 million deaths annually in children 
younger than 5 years, with most deaths occurring in Africa 
and southeast Asia.1,2 A range of interventions might have 
contributed to this reduction, such as safe water and 
hygiene, handwashing, exclusive breastfeeding, measles 
vaccine, improvement in use of oral rehydration salts,3 and 
zinc supplementation.4 Routine rotavirus vaccination is 
expected to further reduce diarrhoeal severity, morbidity, 
and mortality, although recent studies have shown that 
bacterial pathogens, such as non-typhoidal Salmonella, 
Cryptosporidium, Shigella, and Escherichia coli, are im portant 
causes of diarrhoeal deaths within hospitals.5 As a result, 
there is a global call to prioritise examination of risk factors 
for continued diarrhoeal mortality and investigate delivery 
of proven interventions.6
Understanding the presenting clinical features that 
identify children at risk of death is important for front-line 
clinicians who often solely rely on clinical signs to prioritise 
immediate care. Standardised WHO guidance7,8 on man-
agement of diarrhoea with dehydration, which recom-
mends fluid treatment, is available and its usage can 
modify the association between certain clinical risk factors 
and mortality. Therefore, examination of risk factors for 
mortality should also investigate any moderating effect of 
treatment. We investigate clinical risk factors for in-hospital 
death and risk modification associated with intended use of 
WHO fluid treatment guidance in children with diarrhoea 
and dehydration admitted to 13 hospitals in Kenya.9 We use 
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a large routine dataset, based on documentation of clinical 
practice outside specific research settings, with variation 
likely in compliance with clinical guidance and contextual 
factors (captured at the hospital level).
Methods
Study design and participants
For this observational, association study, we analysed 
prospective routine clinical information on admission, 
immediate treatment, and discharge, which was collected 
from 13 first referral-level Kenyan hospitals that constitute 
the Clinical Information Network (CIN). We excluded one 
CIN facility from this analysis because it is contextually 
different from the other CIN facilities; it is staffed by non-
physician clinicians (ie, non-degree trained clinicians) 
and is a health centre with inpatient beds rather than 
being a first-referral hospital. A detailed description of 
CIN facilities has been previously published.
We screened the database for children meeting the 
following criteria: age 1–59 months (as guidelines only 
apply to this group), diarrhoea as a presenting symptom, 
and a full dataset available. We excluded children with only 
a minimal dataset or severe acute malnutrition because 
children with severe acute malnutrition have different 
fluid treatment guidelines.8 Then we identified children 
with diarrhoea as a presenting symptom or diagnosis or 
with dehydration as a diagnosis from the full dataset. 
Within this group, we included in our analyses only 
children with both diarrhoea as a presenting complaint or 
diagnosis and also a primary or secondary diagnosis of 
dehydration (some, severe, shock, or unclassified). These 
criteria defined a population eligible for treatment 
according to WHO and Kenyan guidelines for diarrhoea 
and dehydration. Diarrhoea was considered only a 
presenting symptom rather than a diagnosis in children 
classified as having no dehydration on the standard 
admission form. Data for HIV status were not recorded 
comprehensively in this population, but the analysis 
included children with a diagnosis of HIV. Maternal HIV 
prevalence in Kenya is 6% and the cumulative 5 year 
mother-to-child transmission rate is 15%; as such, we 
expect only a small proportion of children in the dataset to 
have undiagnosed HIV infection.10
The Kenya Medical Research Institute (KEMRI)
Scientific and Ethical Review Committee approved the 
CIN study enabling use of de-identified data without 
individual patient consent.
Procedures
The hospitals use WHO and locally adapted guidance for 
management of common conditions.8–11 In brief, these 
hospitals have implemented two clinical data collection 
tools (standard paediatric admission records and discharge 
forms) and have a dedicated data clerk who enters 
information about admission, treatment, and discharge, 
once the patient is discharged, into a non-proprietary 
electronic tool.12,13 The clerks are trained and regularly 
updated on how to abstract data from medical notes and 
treatment sheets, including fluid prescription sheets, and 
on how to interpret them. Error checks are done before the 
data are uploaded and synchronised into a central server, 
in which further quality checks are done. Any discrepancies 
Research in context
Evidence before this study
Diarrhoea still causes up to 0·6 million deaths annually in children 
younger than 5 years. Research into the optimisation of delivery 
and scaling up of existing interventions are thought to be the 
most urgent priorities to further reduce mortality. However, 
identification of risk factors for diarrhoeal deaths is also among 
the top ten research priorities for the reduction of diarrhoeal 
mortality. To identify studies of risk factors for mortality from 
diarrhoea in children (younger than 18 years), we searched 
PubMed for studies published in English between database 
inception and June 31, 2017. We used various combinations of the 
following search terms: “diarrhoea”, “diarrhea”, “risk”, “odds”, 
“mortality”, and “death”. We also perused the bibliographies of 
retrieved articles. We found case-control studies that reported on 
risk factors of diarrhoeal deaths in children in resource-poor 
settings but found none that used routine clinical data. No 
studies have investigated the effect of use of recommended 
rehydration guidance on mortality in routine clinical practice. 
Most available studies have been done in the context of 
investigating microbial aetiology of diarrhoea rather than clinical 
characteristics, which are what front-line clinicians use for making 
treatment decisions in resource-poor settings.
Added value of this study
This study shows that that children with other signs of severe 
illness (suggestive of comorbidity), and not signs of 
dehydration alone, are most at risk of in-hospital death from 
diarrhoea and dehydration. Our findings also show that 
comorbidities are common and that correct fluid prescription is 
associated with reduced risk of death in these patients.
Implications of all the available evidence
These findings highlight the need for further studies on how to 
manage diarrhoea and dehydration complicated with 
comorbidities. This research is especially important given that 
different fluid management approaches could be 
recommended for children with various comorbidities. We also 
show the benefit of adherence to recommended practice at the 
hospital level. This study also raises questions regarding the 
need to investigate appropriate strategies to optimise delivery 
of recommended guidance in routine settings in hospitals 
within resource-poor settings, which often have inadequately 
trained clinical personnel.
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noted at this stage are raised with respective clerks who 
reconcile them. Periodic visits are made to the participating 
hospitals by the data management team who re-enter a 
number of randomly selected files to ascertain the accuracy 
of data entered by the clerks. A minimal dataset, which 
consists of data required for the routine health information 
system from all admissions (patient age, sex, diagnoses, 
and outcome), is collected for a random sample of 
otherwise eligible admissions in two high-volume 
hospitals (to reduce the data entry workload) and in all 
13 hospitals for surgical or burns cases, admissions 
younger than 1 month, and admissions during periods 
when the single clerk is on leave. The randomisation 
sequence is system generated automatically and not within 
the clerks’ control. A full dataset on clinical presentation, 
diagnoses, treatments, and outcomes is collected on all 
other cases and at all other times. We aimed to investigate 
clinical signs associated with mortality and whether 
prescription of recommended fluid guidance is associated 
with a reduced risk of mortality.
Outcomes
We aimed to examine clinical risk factors for in-hospital 
death and risk modification associated with intended use 
of WHO fluid treatment guidance in children admitted 
with diarrhoea and dehydration across the hospitals. 
Data analysis
Patient characteristics examined include sex, age 
(≤12 months or >12 months), duration of diarrhoea 
(≤14 days or >14 days), length of illness (≤2 days or 
>2 days), history of bloody diarrhoea, malaria status, and 
abnormal signs obtained on examination of various 
systems organised as airway, breathing (respiratory 
system), circulation, hydration status, and disability 
(neurological system). A child was deemed to have an 
abnormal system if any sign within the specific system 
was abnormal (see panel 1 for definitions of abnormal 
signs). In the case of dehydration, we also created a 
variable to represent children with clinical signs indicative 
of severe dehydration (defined in Kenyan guidelines as 
the presence of both sunken eyes and delayed skin pinch). 
Correct fluid prescription was defined based on WHO 
and Kenyan guidance (panel 2).
We did multiple imputation using chained equations to 
deal with missing data. Using Stata version 15.1, we did 
imputation with 100 iterations to produce ten imputed 
datasets on the assumption that co-variable data were 
missing at random.14,15 The imputation model included all 
variables to be considered as risk factors, auxiliary 
variables (fever, history of vomiting, and cough), and 
outcomes, but we excluded any variable with greater than 
30% missingness.16 We studied risk factors for overall in-
hospital mortality and early (within 2 days) in-hospital 
mortality using mixed-effects logistic regression models, 
with patient-level data (level I) nested within hospitals 
(level II) and hospital location in malaria zone as a level II 
fixed effect. Univariable models (unadjusted) were fitted 
on the imputed datasets for each patient characteristic 
and malaria zone location as fixed effects, and hospital 
intercept as a random effect. The multivariable model 
Panel 1: Definition of terms
Airway signs
Abnormal airway signs* (only stridor analysed this study).
Circulatory signs
Presence of any one or more of the following: capillary refill time greater than 2 s 
(delayed capillary refill time), temperature gradient (cold hands and feet), weak pulse 
volume, or pallor.
Comorbidity
Dehydration plus any of the following: malaria, pneumonia, HIV, tuberculosis, anaemia, 
meningitis, rickets, or asthma.
Dehydration signs
Presence of either delayed skin pinch (greater than 1 s) or sunken eyes, or both.
Impaired circulation
Presence of any one or more of the following: weak pulse volume, temperature gradient 
(skin temperature up to shoulder or elbow), or capillary refill time longer than 2 s.
Impaired consciousness
AVPU (Alert, Voice, Pain, Unresponsive) score less than A.
Malaria endemic zone
A hospital was regarded as located in a high malaria endemic zone if malaria diagnoses 
comprised more than 50% of admission diagnoses.
Neurological or disability signs
Presence of any one or more of the following: convulsions, neck stiffness, bulging anterior 
fontanelle, inability to drink or breastfeed, or impaired consciousness.
Pneumonia
History of cough or difficulty breathing, age older than 60 days, lower chest wall indrawing 
or tachypnoea-non-severe pneumonia, and any danger sign (oxygen saturation <90%, 
cyanosis, inability to drink or breastfeed, impaired consciousness, or grunting).
Respiratory illness signs
Presence of any one or more of grunting, tachypnoea, chest indrawing, acidotic 
breathing, crackles, or crepitations.
Severe acute malnutrition
Defined as clinical diagnosis of severe acute malnutrition, mid-upper arm circumference 
less than 11·5 cm, or weight for height Z score less than –3 standard deviations.
Clinical shock
Clinical diagnosis of shock made by clinician or fluid bolus given.
Tachypnoea
Respiratory rate more than 50 breaths per min if aged 12 months or younger, or more 
than 40 breaths per min if older than 12 months.
WHO shock
Presence of all of an AVPU score less than A, weak pulse, and capillary refill time longer 
than 3 s in the presence of diagnosis of dehydration.
*Abnormal airway signs include obstructed (stridor) or absent breathing, central cyanosis, or severe respiratory distress. Only 
stridor was included in the analysis as the other signs were rare while severe respiratory distress is not collected in the database.
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(model II; adjusted) was constructed using all patient 
characteristics and a backward variable selection pro-
cedure with a p value for exclusion of 0·05, while 
maintaining the same multilevel structure as the 
univariable model. A priori, we decided to include age, 
sex, and malaria diagnosis in the adjusted model. 
Final model estimates were derived using Rubin rules.14 
Final risk factors are variables independently associ-
ated with outcome in the multivariable model (Wald 
test p value <0·05). Because our analysis focuses on a 
population in whom we have excluded no dehydration, 
we also investigated the association be tween signs 
identified as risk factors in model II and mortality in a 
broader population of children admitted with diarrhoea 
using the same approach as done for those with diarrhoea 
and dehydration to investigate the general isability of 
findings.
We investigated effect modification of admission fluid 
prescription on risk of death in children with signs of 
dehydration, abnormal respiratory signs, impaired 
circulation, anaemia, and abnormal neuro logical signs, 
by including a binary term for correct initial fluid 
prescription in the model for early death (within 2 days 
from admission). We calculated the relative excess odds 
due to interaction, the attributable proportion, and the 
multiplicative int eraction odds ratio (OR).17 Interactions 
were analysed in the final model (model II) one at a time. 
Analysis for effect modification was restricted to early 
deaths because we hypothesised that this is the group 
whose outcome might be affected by fluid management 
at admission. Our database collected only fluid prescribed 
at admission. Patients with no information on fluid 
management were excluded from the analysis for effect 
modification.
Data sharing statement
Data for this report are under the primary jurisdiction of 
the Ministry of Health in Kenya. Enquiries about using 
the data can be made to the KEMRI-Wellcome Trust 
Research Programme Data Governance Committee.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of this manuscript. SA, PA, DG, AA, GI, KS, and 
ME had access to the raw data. The corresponding author 
had full access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Between Oct 1, 2013, and Dec 1, 2016, 19 839 (36%) of 
55 048 eligible paediatric patients with a full dataset 
admitted to the 13 CIN hospitals had diarrhoea or 
dehydration. 8562 patients had both diarrhoea and 
dehydration and 9618 had diarrhoea as a symptom only 
(without dehydration; figure 1). We did the analysis to 
determine risk factors and effect modification with fluid 
therapy in children who had both diarrhoea and 
dehydration (n=8562). 
Among those with diarrhoea and dehydration (n=8562), 
5160 (60%) had some dehydration, 2434 (28%) had severe 
dehydration, 431 (5%) had shock, and 537 (6%) had no 
Figure 1: Study profile
CIN=Clinical Information Network.
95 938 paediatric patients admitted to hospitals
40 890 ineligible
 1891 admitted to health centre 
 7474 severe acute malnutrition
 4197 burns or surgical cases
 6687 younger than 30 days
 3777 admitted during the clerk’s leave period
 6066 have minimum dataset
 10 808 older than 5 years
55 048 eligible
35 209 did not have diarrhoea or dehydration 
19 839 had diarrhoea or dehydration
 1659 had dehydration without diarrhoea
 8562 had dehydration and diarrhoea
 9618 had diarrhoea as a symptom (no dehydration)
11 277 not analysed
 1659 had dehydration without diarrhoea
 9618 had diarrhoea as a symptom (no dehydration)
8562 with dehydration and diarrhoea analysed for early 
 mortality (death ≤2 days)
Panel 2: Definitions of correct fluid prescription based on 
WHO and Kenyan guidance
In this study, either WHO plan B, WHO plan C, or shock 
management7,8 were correctly prescribed.
Plan B was correct when given to children classified as having 
some dehydration and who had not been prescribed bolus 
fluid and received oral fluid (prescribed for a duration of 4 h 
or prescribed to be given at regular intervals) or prescribed 
intravenous fluid (not plan C or fluid bolus and volume 
<200 mL/kg for a duration of 24 h) plus oral fluid.
Plan C was correct when given to children with a diagnosis of 
severe dehydration, who had not been prescribed bolus, and 
in whom oral fluid was used. Correct volume of plan C was 
30 mL/kg for step 1 and 100 mL/kg for step 2. The correct 
duration of plan C was 6 h or less.
Shock management was correct in children indicated as 
having shock and prescribed fluid bolus plus correct plan C. 
Intravenous fluid or bolus was correct if normal (0·9%) saline 
or Ringer’s lactate was used.
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classification for the degree of dehydration (table 1). The 
overall mortality was 9% (759 of 8562) and diarrhoea and 
dehydration together were associated with 28% (759 of 
2711) of all deaths in eligible children in the full dataset. 
Case fatality in children with some dehydration was 5% 
(240 of 5160), severe dehydration was 13% (310 of 2434), 
shock was 42% (179 of 431), and in unclassified cases 
was 6% (30 of 537). 205 (27%) of the 759 deaths 
occurred within the first day and a total of 486 (64%) 
had died within 2 days; median duration to death was 
1 day (IQR 0–2). At baseline, fever (6153 [76%] of 8067) and 
vomiting (6780 [83%] of 8169) were common. Although 
only 37 (<1%) of 8562 patients fulfilled the WHO criteria 
for shock (panel 1), a clinical diagnosis of shock was 
present in 537 (6%) of 8562 patients. Most participants 
(7184 [84%] of 8562) had a second diagnosis (comorbidity), 
and these included, among others, slide-positive malaria 
(2766 [32%]), pneumonia (3065 [36%]), anaemia (428 
[5%]), and possible meningitis (642 [8%]). Median ages for 
admitted patients was 12·0 months (IQR 8·0–18·0).
In 537 (6%) of 8562 patients, information on fluid 
prescribed was missing. Correct fluid (fluid type, volume, 
use of rate on infusion recommended for age of child) 
was prescribed in 3760 (44%) of 8025 participants. 
Among children with information on fluid prescribed, 
WHO plan B was correctly prescribed to 3398 (66%) of 
5160 participants, WHO plan C to 331 (14%) of 
2434 participants, and shock fluid prescriptions to 
31 (7%) of 431 participants. 3569 (45%) of 8025 participants 
received at least some intravenous fluid whereas the rest 
of the participants received oral fluids only. Because 
intravenous fluids were more likely to be given to patients 
with more severe forms of dehydration, we included 
use of intravenous fluids in our analysis for risk 
factors as a proxy for disease severity. Antibacterials were 
pre scribed in 5250 (61%) of 8562 participants, anti-
malarials in 2621 (32%) of 8252 participants, and any 
antimicrobial (antibacterial or antimalarial) in 
6321 (74%) of 8562 participants. Electrolyte testing was 
generally unavailable across the hospitals.9
All variables included in the analysis had less 
than 27% of missing values (table 1), but a multilevel 
model using complete cases would have incorporated 
only 24% of cases (at least one missing variable). 
The population characteristics in the imputed data were 
similar to the characteristics before imputation (table 1).
Analysis of the association of each covariable with 
mortality in models using imputed data suggested that 
female sex, age of 12 months or younger, length of illness 
of more than 2 days, diarrhoea duration of more than 
14 days, abnormal airway signs, abnormal respiratory 
signs, abnormal circulatory signs, pallor, signs of 
dehydration, use of intravenous fluids (proxy for severity), 
and abnormal neurological signs were all significantly 
associated with in-hospital death across hospitals, 
whereas bloody diarrhoea and malaria parasitaemia were 
not (figure 2). Backward selection excluded bloody 
diarrhoea; as such, it was not included in the final 
multivariable model.
In model II, with adjustment of all patient-level 
covariables, age of 12 months or younger (adjusted-
OR [AOR] 1·71, 95% CI 1·42–2·06), female sex (AOR 1·41, 
1·19–1·66), diarrhoea duration of more than 14 days 
(2·10, 1·42–3·12), abnormal respiratory signs (3·62, 
2·95–4·44), abnormal circulatory signs (2·29, 1·89–2·77), 
pallor (2·15, 1·76–2·62), use of intravenous fluids (1·68, 
1·41–2·00), and abnormal neurological signs (3·07, 
Complete dataset Missing data for 
variable 
(n=8562)
Mean proportion 
with characteristic 
present in imputed 
data (n= 85 620)
Total Characteristic 
present
Demographics
Girls 8485 3724 (47%) 77 (1%) 37 574 (44%)
Age ≤12 months 8562 4941 (58%) 0 49 410 (58%)
History
Length of illness >2 days 8104 5353 (66%) 458 (5%) 56 292 (66%)
Diarrhoea >14 days 7465 252 (3%) 1097 (13%) 2843 (3%)
Diarrhoea bloody 7585 277 (4%) 977 (11%) 3174 (4%)
Airway
Stridor 7453 97 (1%) 1109 (13%) 1147 (1%)
Airway signs 7453 97 (1%) 1109 (13%) 1147 (1%)
Breathing or respiratory
Tachypnoea 6342 1972 (31%) 2220 (26%) 25 570 (30%)
Grunting 7687 637 (8%) 875 (10%) 7038 (8%)
Indrawing 7780 1621 (21%) 782 (9%) 17 185 (20%)
Crackles or crepitations 7863 1193 (15%) 699 (8%) 12 860 (15%)
Respiratory signs 8161 3141 (39%) 401 (5%) 35 973 (42%)
Circulation
Capillary refill >2 s 6404 705 (11%) 2158 (25%) 9481 (11%)
Temperature gradient 6270 655 (10%) 2292 (27%) 8921 (11%)
Weak pulse volume 7381 946 (13%) 1181 (14%) 11 050 (13%)
Circulatory signs 7697 1641 (21%) 865 (10%) 20 079 (23%)
Pallor 7954 1240 (16%) 608 (7%) 13 392 (16%)
Dehydration
Delayed skin pinch 7562 3569 (47%) 1000 (12%) 40 113 (47%)
Sunken eyes 7511 3875 (52%) 1051 (12%) 42 843 (50%)
Dehydrations signs 7889 4998 (63%) 673 (8%) 54 025 (63%)
Dehydrations signs (severe) 7889 2446 (31%) 673 (8%) 28 931 (34%)
Disability or neurological
Convulsions 7836 856 (11%) 726 (9%) 9332 (11%)
Inability to drink or breastfeed 7533 1864 (25%) 1029 (12%) 20 906 (25%)
Impaired consciousness 
(AVPU<A)
7974 878 (11%) 588 (7%) 9453 (11%)
Neurological signs 8118 2263 (28%) 444 (5%) 24 773 (29%)
Others
Malaria 8562 2771 (32%) 0 27 710 (32%)
Death 8562 759 (9%) 0 7590 (9%)
Data are n (%) unless stated otherwise. AVPU=Alert, Voice, Pain, Unresponsive.
Table 1: Clinical characteristics at admission of patients with diarrhoea and dehydration
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2·54–3·70) remained associated with in-hospital 
mortality within hospital clusters (figure 2). Notably, 
within this population, all of whom had diarrhoea and 
dehydration, individual signs of dehydration and 
presence of both sunken eyes and delayed skin pinch 
(severe dehydration) were not independently associated 
with in-hospital death (severe dehydration AOR 1·08, 
0·87–1·35) within hospital clusters. However, when the 
same model was used in an analysis of the broader 
population of all patients with diarrhoea or dehydration 
(n=19 839; figure 1), signs of dehydration were indepen-
dently associated with in-hospital death (AOR 1·22, 
1·01–1·47; further data available on request). Length of 
illness of more than 2 days, abnormal airway signs, 
malaria diagnosis, and residence within a malaria 
endemic zone were not associated with death in the 
multivariable analysis (model II). Similar associations 
were seen when the multivariable model was done with 
the outcome as early in-hospital death, with the exception 
of diarrhoea duration of more than 14 days, which no 
longer showed a clear association with mortality 
(AOR 1·43, 0·87–2·34). When bloody diarrhoea was 
added to the final multivariable model, it was not 
associated with the outcome and the effect of the other 
covariates was not altered.
In analyses restricted to the stratum for whom the fluid 
prescription was correct, the strength of association (ORs) 
with early in-hospital mortality was, in general, con-
siderably lower than in the stratum in which fluid pre-
scriptions were incorrect, even after adjustment for use of 
intravenous fluids (a proxy for severity). In fact, positive 
multiplicative interactions (OR>1) for association of 
incorrect fluid management with death in children with 
dehydration signs (OR 1·50, 95% CI 0·79–2·88), 
respiratory signs (OR 1·23, 0·68–2·24), and pallor 
(OR 1·70, 0·95–3·02) are evidence of interaction (figure 3). 
Further more, likely presence of additive interaction 
(relative excess odds due to interaction is not zero) point to 
the potential public health benefit of being able to correctly 
prescribe fluid regimens (table 2). The predicted probability 
of early in-hospital death was reduced by 6% when derived 
from model II with correct fluid prescription compared 
with when fluid prescription is wrong.
Discussion
A study6 using the Child Health and Nutrition Research 
Initiative’s methodology recently identified risk factors 
for diarrhoeal deaths as a research priority. This study 
investigated clinical features associated with mortality 
and whether, for early deaths, associations are modified 
by prescribed fluid therapy in accordance with WHO and 
Kenyan guidance in children with both diarrhoea and 
dehydration. We used routinely collected data from 
13 first-level referral hospitals in Kenya involved in a 
collaborative effort to improve availability of routine data 
on admitted children and the management of common 
conditions.7–9 We excluded children who had severe acute 
malnutrition, a known major risk factor for mortality 
with specific fluid management guidance,7,8 and children 
younger than 30 days or older than 5 years because no 
standard rehydration guidelines exist for those ages. We 
did not have microbial cultures of stool or blood but 
malaria testing is done consistently by these hospitals in 
their own laboratories.9
In our study of 8562 children admitted with both 
diarrhoea and dehydration, we found that most (>80%) 
had at least one additional diagnosis (comorbidity). We 
also note that diarrhoea not accompanied by clinically 
diagnosed dehydration is a common symptom in a range 
of diseases. Among participants with diarrhoea and 
dehydration (representing 16% of all admissions and 
associated with 28% of all death), respiratory signs, 
circulatory impairment, pallor, neurological signs and 
symptoms, prolonged diarrhoea, age younger than 
1 year, and female sex were associated with increased 
risk of in-hospital death. Our findings are consistent 
with studies that have shown impaired consciousness, 
convulsions,18 signs of pneumonia,19,20 anaemia, weak 
pulse volume,20 longer duration of preadmission illness,21 
and persistent diarrhoea22–25 as risk factors for mortality 
in children with diarrhoea. Respiratory signs might in 
Figure 2: Risk factors for in-hospital mortality in children with diarrhoea and dehydration
(A) Association of each covariable with in-hospital mortality in models using imputed data. (B) Association with in-
hospital mortality after adjustment for all patient-level covariables. *Odds ratios not calculated. †Proxy measure for 
illness severity.
Unadjusted odds ratios
A
Adjusted odds ratios (model II)
B
Malaria endemic area*
Female sex
Respiratory signs
Neurological signs
Malaria diagnosis
Length of illness >2 days
Intravenous fluid administered†
Diarrhoea bloody
Diarrhoea >14 days
Dehydration signs
Circulatory signs
Pallor
Airway signs
Age ≤12 months
310 4 520 31 5 7642
*
Figure 3: Risk factors and interaction with fluid management for early in-hospital mortality
Unadjusted odds ratios
Respiratory signs
Neurological signs
Dehydration signs
Circulatory signs
Pallor
Airway signs
310 5 7642
Adjusted odds ratios (model II) Adjusted odds ratios
(model II-interactions)
310 542 310 42
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fact be indicative of pneumonia comorbidity. Female sex 
and younger age (<1 year), which were significantly 
associated with mortality in this study, have also been 
found to be risk factors in other studies. Our study did 
not investigate reasons for higher mortality in female 
participants than in male participants; some of the 
reasons suggested include social inequality and gender 
bias, but whether these factors are also important in 
Kenya is unclear.26
In our analysis of children with information on fluid 
prescribing, we found that correct fluid prescription was 
associated with reduced odds of death in participants with 
various clinical signs. Recommended fluid regimens are 
more complex for children who are more severely ill and 
might more often be wrongly prescribed. As well as 
adjusting for specific signs of severity, we also adjusted for 
the choice to use intravenous fluid therapy as a possible 
additional indication of the perceived disease severity. 
Overall, our findings suggest a potential public health 
benefit from ensuring or improving correct fluid 
prescription practices. In the exploratory analyses (data not 
shown), most incorrect fluid prescriptions in this study 
involved inadequate volumes or use of recom mended 
volumes that were given over longer than recom mended 
durations. Any efforts to improve correct fluid management 
will have to deal with the problem of comorbidity in 
children with diarrhoea and dehydration, something not 
covered in existing guidelines. The importance of tailoring 
fluid therapy to specific populations has been highlighted 
by the FEAST study. This large multicentre clinical trial of 
fluid treatment in African children with impaired perfusion 
and febrile non-diarrhoeal illnesses showed rapid fluid 
adminis tration to be harmful in non-diarrhoeal cases.27 
Special precaution was unlikely in the data presented 
because the data presented here represent prescription by 
front-line clinicians (mainly intern doctors or non-
physician clinicians) who generally rely on guidelines and 
any decisions to deviate are made by senior clinicians much 
later after admission and are not reflected in this analysis.
Case fatality in the present study (9%) is similar to that 
found in a study28 involving two hospitals in western 
Kenya (9%); however, the patient population in the other 
study was different from ours because it included all 
children with diarrhoea and children with malnutrition. 
The study28 in western Kenya and the recent GEMS studies 
have shown that bacterial pathogens, including non-
typhoidal Salmonella, Cryptosporidium, Shigella, and E coli, 
are important risk factors for death and severe disease and 
that rotavirus was not an important cause of in-hospital 
mortality.5 These findings have led to calls for studies on 
bacterial aetiology of diarrhoea and studies on anti-
microbial resistance. Like the study in western Kenya, in 
our study, antibiotics were given to 60% of children with 
diarrhoea or dehydration, with co morbidities providing an 
indication for antibiotic use; however, most of the 
antibiotics used might not be effective against gut 
infections. Antibiotics are not routinely recommended and 
their use in the present study was a proxy for comorbidity.
The CIN has enabled improvements in documentation 
of the assessment, diagnosis, and treatment at admission 
of conditions since its inception and it uses a robust data 
capture system to try and optimise data quality.7–9 However, 
some data are missing and we employed imputation to 
maximise use of all available data. We do not have insight 
into whether the treatments prescribed at admission are 
accurately given—something that can be compromised by 
resource unavailability and staff shortages.29,30 We also 
cannot be sure that clinicians are correct in their diagnosis 
and assessment or that they prescribe the right fluid 
regimens to the right patients. Data from such routine 
settings do not provide any insight on microbial aetiological 
diagnoses or on biochemical tests that might help assess 
severity of disease. Multiple imputation for missing data is 
based on an assumption that data are missing at random, 
which is difficult to ascertain. Finally, CIN does not collect 
data on all the care children receive across the period of 
their admission. Despite these limitations, this large 
dataset does offer a picture of routine admission 
characteristics and treatments across multiple sites and 
over a prolonged period of time, and findings might 
therefore be generalisable to similar African settings.
Children with diarrhoea and dehydration who are at 
most risk of in-hospital death are those with other signs 
of severe disease (comorbities) as opposed to those with 
Multiplicative 
interaction
Fluid wrong and symptom 
present (OR10)
Fluid right and symptom 
present (OR11)
Fluid right and symptom 
absent (OR01)
RERI Attributable proportion
Pallor 1·70 (0·95 to 3·02) 2·16 (1·66 to 2·82) 1·07 (0·69 to 1·67) 0·29 (0·21 to 0·41) –0·38 (–1·07 to 0·31) –0·35 (–1·09 to 0·38)
Circulatory 0·95 (0·53 to 1·73) 1·92 (1·47 to 2·51) 0·64 (0·40 to 1·03) 0·35 (0·25 to 0·50) –0·63 (–1·19 to –0·06) –0·98 (–2·06 to 0·11)
Dehydration signs only 1·50 (0·79 to 2·88) 0·96 (0·70 to 1·33) 0·38 (0·26 to 0·55) 0·26 (0·15 to 0·45) 0·25 (–0·18 to 0·48) 0·40 (–0·53 to 1·33)
Neurological 0·86 (0·51 to 1·48) 3·57 (2·75 to 4·64) 1·15 (0·77 to 1·72) 0·37 (0·25 to 0·54) –1·80 (–2·71 to –0·88) –1·56 (–2·61 to –0·52)
Respiratory 1·23 (0·68 to 2·24) 3·18 (2·35 to 4·31) 1·17 (0·80 to 1·73) 0·30 (0·18 to 0·49) –1·31 (–2·16 to –9·45) –1·11 (–1·90 to –0·33)
Interaction exists if RERI is not zero (RERI=OR11 – OR10 – OR01 + 1). A negative value of RERI implies reduced risk due to interaction with fluid treatment. The attributable proportion is a measure of the proportion 
of the risk in the doubly exposed group that is due to the interaction itself. An interaction exists if the attributable proportion is not zero (attributable proportion=RERI/OR11). A negative value of the attributable 
proportion suggests that interaction reduces the risk of outcome (death). Multiplicative interaction=OR11/(OR10 ×  OR01). Presence of interaction on either additive or multiplicative scales indicates that both 
exposures have an effect on the outcome. The reference group was fluid wrong and symptom absent (OR00)=1·00. RERI=relative excess risk due to interaction.
Table 2: Interactions of fluid management with risk factors for in-hospital early deaths 
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uncomp licated dehydration. Importantly, prescription of 
recom mended rehydration guidelines reduces risk of 
death in this group of children. However, correct fluid 
prescription might be an indicator of improved attention 
to the provision of good overall care, including other 
treatments such as antibiotics and nursing care, rather 
than fluid management alone. Strategies to optimise 
delivery of recommended guidance should be ac-
companied by studies on the management of dehyd-
ration in children with comorbidities, the vulnerability of 
female children, and the delivery of immediate care. 
Future research that investigates diar rhoea aetiology, that 
includes an enhanced range of diagnostic tests (including 
for comorbidities), and that effectively standardises the 
delivery of fluid therapy in accordance with guidelines, 
would help tease out more specific risk factors for poor 
outcome and could support newer management ap-
proaches that target more specific patient groups.
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